0 CHECKOUT

PRODUCT FILTERS

REGION

12,683
9,329
9,256
8,606
8,563

COUNTRY

8,177
1,128
507
473
398

CATEGORIES

  • 2,966
  • 2,597
  • 2,223
  • 2,072
  • 2,071
  • 1,879
    • 353
    • 265
    • 257
    • 254
    • 216
    • 209
    • 181
    • 162
    • 160
    • 148
    • 145
    • 136
    • 100
    • 98
  • 1,480
  • 1,414
  • 1,344
  • 1,291
  • 1,278
  • 1,016
  • 1,005
    • 250
  • 937
  • 592
  • 557
  • 514
  • 407
  • 384
    • 406
      • 57
    • 113
  • 378
  • 163
  • 131
SHOW ALL

PRICE

5,144
9,907
16,619
32,410

PUBLISHED

2,184
7,414
15,613
32,410

PRODUCT TYPE

25,448
2,754
2,560
729
530
223
70
39
29
20
6
1
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

Diabetic Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Diabetic Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016

“ Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Relapsing Multiple Sclerosis (RMS). The report...

Published:  March 2016
Price:  From

Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  March 2016
Price:  From

Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune...

Published:  March 2016
Price:  From

Phenylketonuria (PKU)-Pipeline Insights, 2016

“ Phenylketonuria (PKU)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Phenylketonuria (PKU). The report covers the product profiles...

Published:  March 2016
Price:  From

Acromegaly-Pipeline Insights, 2016

“ Acromegaly-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Acromegaly. The report covers the product profiles in various stages...

Published:  March 2016
Price:  From

Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016

“ Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Idiopathic Pulmonary Fibrosis. The report covers...

Published:  March 2016
Price:  From

Fragile X Syndrome-Pipeline Insights, 2016

“ Fragile X Syndrome-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Fragile X Syndrome. The report covers the product profiles...

Published:  March 2016
Price:  From

Collaborative Genomics Projects: A Comprehensive Guide

Collaborative Genomics Projects: A Comprehensive Guide contains operational procedures, policy considerations, and the many lessons learned by The Cancer Genome Atlas Project. This book guides the reader...

Published:  February 2016
Price: 

Diabetic Neuropathic Pain - Pipeline Review, H1 2016

Diabetic Neuropathic Pain - Pipeline Review, H1 2016 Summary ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape. The...

Published:  February 2016
Price:  From

Diabetic Nephropathy - Pipeline Review, H1 2016

Diabetic Nephropathy - Pipeline Review, H1 2016 Summary The report ‘Diabetic Nephropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape. The report...

Published:  February 2016
Price:  From

Systemic Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Systemic Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  March 2016
Price:  From

Musculoskeletal Pain-Pipeline Insights, 2016

“ Musculoskeletal Pain-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Musculoskeletal Pain. The report covers the product profiles...

Published:  March 2016
Price:  From

Pompe Disease-Pipeline Insights, 2016

“ Pompe Disease-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Pompe Disease. The report covers the product profiles in various...

Published:  March 2016
Price:  From

Low Back Pain-Pipeline Insights, 2016

“ Low Back Pain-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Low Back Pain. The report covers the product profiles in various...

Published:  March 2016
Price:  From

Psoriatic Arthritis-Pipeline Insights, 2016

“ Psoriatic Arthritis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Psoriatic Arthritis. The report covers the product profiles...

Published:  March 2016
Price:  From

Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients